EBUSCO HOLDING NV (EBUS.AS)

NL0015002AG2 - Common Stock

1.15  -0.01 (-1.02%)

Fundamental Rating

2

Overall EBUS gets a fundamental rating of 2 out of 10. We evaluated EBUS against 97 industry peers in the Machinery industry. EBUS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EBUS is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

EBUS had negative earnings in the past year.
In the past year EBUS has reported a negative cash flow from operations.
In multiple years EBUS reported negative net income over the last 5 years.
EBUS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

EBUS has a Return On Assets of -50.80%. This is amonst the worse of the industry: EBUS underperforms 95.70% of its industry peers.
Looking at the Return On Equity, with a value of -120.90%, EBUS is doing worse than 93.55% of the companies in the same industry.
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROIC N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EBUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

EBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EBUS has more shares outstanding
EBUS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EBUS has a worse debt to assets ratio.

2.2 Solvency

EBUS has an Altman-Z score of -1.77. This is a bad value and indicates that EBUS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.77, EBUS is not doing good in the industry: 84.95% of the companies in the same industry are doing better.
EBUS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
EBUS has a better Debt to Equity ratio (0.11) than 86.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -1.77
ROIC/WACCN/A
WACC6.12%

2.3 Liquidity

A Current Ratio of 1.30 indicates that EBUS should not have too much problems paying its short term obligations.
EBUS has a Current ratio of 1.30. This is in the lower half of the industry: EBUS underperforms 68.82% of its industry peers.
EBUS has a Quick Ratio of 1.30. This is a bad value and indicates that EBUS is not financially healthy enough and could expect problems in meeting its short term obligations.
EBUS has a Quick ratio of 0.56. This is amonst the worse of the industry: EBUS underperforms 92.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.56

6

3. Growth

3.1 Past

The earnings per share for EBUS have decreased strongly by -224.80% in the last year.
The Revenue for EBUS has decreased by -15.07% in the past year. This is quite bad
EBUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.83% yearly.
EPS 1Y (TTM)-224.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%

3.2 Future

The Earnings Per Share is expected to grow by 17.17% on average over the next years. This is quite good.
Based on estimates for the next years, EBUS will show a very strong growth in Revenue. The Revenue will grow by 48.07% on average per year.
EPS Next Y-2.21%
EPS Next 2Y25.55%
EPS Next 3Y25.17%
EPS Next 5Y17.17%
Revenue Next Year6.25%
Revenue Next 2Y25.34%
Revenue Next 3Y34.82%
Revenue Next 5Y48.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EBUS. In the last year negative earnings were reported.
Also next year EBUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EBUS's earnings are expected to grow with 25.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.55%
EPS Next 3Y25.17%

0

5. Dividend

5.1 Amount

EBUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EBUSCO HOLDING NV

AMS:EBUS (1/3/2025, 7:00:00 PM)

1.15

-0.01 (-1.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.09%
Inst Owner ChangeN/A
Ins Owners28.64%
Ins Owner ChangeN/A
Market Cap75.29M
Analysts36.36
Price Target1.19 (3.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-87.76%
PT rev (3m)-73.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-466.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 1.04
EV/EBITDA N/A
EPS(TTM)-5.18
EYN/A
EPS(NY)-1.94
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.34
OCFYN/A
SpS1.51
BVpS1.87
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.11%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.56
Altman-Z -1.77
F-Score1
WACC6.12%
ROIC/WACCN/A
Cap/Depr(3y)143.07%
Cap/Depr(5y)111.08%
Cap/Sales(3y)14.44%
Cap/Sales(5y)9.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-224.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
EPS Next Y-2.21%
EPS Next 2Y25.55%
EPS Next 3Y25.17%
EPS Next 5Y17.17%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%
Revenue Next Year6.25%
Revenue Next 2Y25.34%
Revenue Next 3Y34.82%
Revenue Next 5Y48.07%
EBIT growth 1Y-76.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.98%
EBIT Next 3Y37.96%
EBIT Next 5Y29.69%
FCF growth 1Y-17.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.84%
OCF growth 3YN/A
OCF growth 5YN/A